Sharon Lahiri is an Endocrinology/Metabolic physician affiliated with Henry Ford Health System. OpenAlex indexes 28 publications with 261 citations (h-index 8).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3031 W Grand Blvd
Detroit, MI 482023046
Telephone
313-916-2600Provider last certified this registry record 3 May 2024.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Xeris Pharmaceuticals, Inc.Program year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
57.5%GLP-1 receptor agonist19.9%Ozempic39%Mounjaro37%Trulicity25%Part D≥26 patientsInsulin Analog16.7%Lantus Solostar40%Novolog Flexpen24%Humalog Kwikpen U-10017%Toujeo Solostar10%Tresiba Flextouch U-10010%Part D<11 patients+ 4 more classes in this area
Hormonal (systemic)
29.1%l-Thyroxine18.2%Levothyroxine Sodium85%Synthroid15%Part D<11 patientsThyroid Hormone Synthesis Inhibitor9.5%Methimazole100%Part D≥24 patients+ 1 more class in this area
Cardiovascular
8.8%Statin8.8%Rosuvastatin Calcium83%Pravastatin Sodium17%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- SAT-071 Gender Differences in Cardiometabolic Disease and Outcomes in Patients with Acromegaly
Journal of the Endocrine Society
2025 - SAT-075 Gender Differences in Solid Organ Malignant Tumors and Mood Disorders in Patients with Acromegaly
Journal of the Endocrine Society
2025 - 7330 Acute Hypercalcemic Renal Failure As A Presenting Manifestation Of Primary Hyperparathyroidism Due To Atypical Adenoma
Journal of the Endocrine Society
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Steven Kalkanis, MD
Henry Ford Health System
Shirish Gadgeel, MD
Henry Ford Health System
Mani Menon, MD
Henry Ford Health System
Marcus Zervos, MD
Henry Ford Health System
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”